SYRE - Company ID 0001636282
As of 2026-09-07, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $7.73 B, making it the #1112 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $7.73 B |
| 2026-09-06 | $7.73 B |
| 2026-09-05 | $7.73 B |
| 2026-09-04 | $7.73 B |
| 2026-09-03 | $7.58 B |
| 2026-09-02 | $7.56 B |
| 2026-09-01 | $7.69 B |
| 2026-08-31 | $7.69 B |
| 2026-08-30 | $7.85 B |
| 2026-08-29 | $7.85 B |
| 2026-08-28 | $7.87 B |
| 2026-08-27 | $8.13 B |
As of 2026-09-07, Spyre Therapeutics, Inc. (SYRE) has a market capitalization of $7.73 B, making it the #1112 most valuable US-listed company.
Spyre Therapeutics, Inc. is the #1112 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $8.13 B |
| 2026-08-25 | $9.30 B |
| 2026-08-24 | $9.26 B |
| 2026-08-23 | $9.25 B |
| 2026-08-22 | $9.25 B |
| 2026-08-21 | $9.25 B |
| 2026-08-20 | $9.36 B |
| 2026-08-19 | $9.46 B |
| 2026-08-18 | $9.29 B |
| 2026-08-17 | $9.08 B |
| 2026-08-16 | $9.00 B |
| 2026-08-15 | $9.00 B |
| 2026-08-14 | $8.97 B |
| 2026-08-13 | $8.84 B |
| 2026-08-12 | $9.04 B |
| 2026-08-11 | $8.92 B |
| 2026-08-10 | $9.10 B |
| 2026-08-09 | $9.11 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.